Ignite Creation Date:
2024-05-05 @ 11:58 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00194753
Status:
COMPLETED
Last Update Posted:
2012-09-13
First Post:
2005-09-14
Brief Title:
Adjuvant Therapy for High-Risk Breast Cancer With Wkly Adriamycin Oral Cytoxan With G-CSF for 12 Wks Wkly Taxol x 12
Sponsor:
University of Washington
Organization:
University of Washington
Organization Data
Organization:
University of Washington
Class:
OTHER
Study ID:
18229-A
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Washington
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Bristol-Myers Squibb | INDUSTRY |
| Amgen | INDUSTRY |